Market Overview

Benzinga's Top Initiations

Related RPRX
Earnings Scheduled For August 11, 2014
FDA Confirms Endpoints of Androxal Study

Analysts at Lazard Capital initiated coverage on shares of Repros Therapeutics (NASDAQ: RPRX) with a “buy” rating. The target price for Repros Therapeutics is set to $26. Repros Therapeutics' shares closed at $11.83 yesterday.

Citigroup initiated coverage on shares of Workday (NYSE: WDAY) with a “neutral” rating. The target price for Workday is set to $58. Workday's shares closed at $52.61 yesterday.

Wedbush initiated coverage on shares of Denny's (NASDAQ: DENN) with an “outperform” rating. The target price for Denny's is set to $6. Denny's stock closed at $4.98 yesterday.

Analysts at Credit Suisse initiated coverage on shares of Williams-Sonoma (NYSE: WSM) with a “neutral” rating. The target price for Williams-Sonoma is set to $49. Williams-Sonoma's shares closed at $44.90 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (DENN + RPRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional